LA JOLLA PHARMACEUTICAL CO Selling, General and Administrative Expense
LA JOLLA PHARMACEUTICAL CO reported Selling, General and Administrative Expense of $9.76 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-08-15
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for the quarter ending 2022-06-30 was $9.76M, a 8.51% increase year-over-year.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for the quarter ending 2022-03-31 was $10.27M, a 17.35% increase year-over-year.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for the quarter ending 2021-12-31 was $9.00M, a 1.13% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for the quarter ending 2021-09-30 was $8.63M, a 30.91% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for fiscal 2021 was $35.39M, a 7.92% decline from fiscal 2020.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for fiscal 2020 was $38.43M, a 14.86% decline from fiscal 2019.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for fiscal 2019 was $45.13M.
- LA JOLLA PHARMACEUTICAL CO selling, general and administrative expense for fiscal 2017 was $30.85M, a 84.74% increase from fiscal 2016.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2022-06-30 | $9.76M 10-Q · filed 2022-08-15 | $20.04M 10-Q · filed 2022-08-15 | $29.04M derived: sum of 3 quarters · filed 2022-08-15 | $37.67M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | $10.27M 10-Q · filed 2022-05-16 | $19.28M derived: sum of 2 quarters · filed 2022-05-16 | $27.91M derived: sum of 3 quarters · filed 2022-05-16 | $36.91M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $17.64M derived: sum of 2 quarters · filed 2022-03-09 | $26.63M derived: sum of 3 quarters · filed 2022-08-15 | $35.39M 10-K · filed 2022-03-09 | |
| 2021-09-30 | $8.63M 10-Q · filed 2021-11-04 | $17.63M derived: sum of 2 quarters · filed 2022-08-15 | $26.38M 10-Q · filed 2021-11-04 | $35.49M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-06-30 | $9.00M 10-Q · filed 2022-08-15 | $17.75M 10-Q · filed 2022-08-15 | $26.86M derived: sum of 3 quarters · filed 2022-08-15 | $39.35M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $8.76M 10-Q · filed 2022-05-16 | $17.86M derived: sum of 2 quarters · filed 2022-05-16 | $30.35M derived: sum of 3 quarters · filed 2022-05-16 | $39.03M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $21.60M derived: sum of 2 quarters · filed 2022-03-09 | $30.28M derived: sum of 3 quarters · filed 2022-03-09 | $38.43M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $12.49M 10-Q · filed 2021-11-04 | $21.17M derived: sum of 2 quarters · filed 2021-11-04 | $29.32M 10-Q · filed 2021-11-04 | $40.03M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $8.68M 10-Q · filed 2021-08-05 | $16.83M 10-Q · filed 2021-08-05 | $27.54M derived: sum of 3 quarters · filed 2021-08-05 | $38.32M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $8.15M 10-Q · filed 2021-05-07 | $18.86M derived: sum of 2 quarters · filed 2021-05-07 | $29.64M derived: sum of 3 quarters · filed 2021-05-07 | $40.97M derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | $10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $21.49M derived: sum of 2 quarters · filed 2021-03-08 | $32.81M derived: sum of 3 quarters · filed 2021-03-08 | $45.13M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $10.78M 10-Q · filed 2020-11-09 | $22.11M derived: sum of 2 quarters · filed 2020-11-09 | $34.42M 10-Q · filed 2020-11-09 | -$8.25M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $11.32M 10-Q · filed 2020-08-06 | $23.64M 10-Q · filed 2019-08-01 | -$19.03M derived: sum of 3 quarters · filed 2020-08-06 | $2.11M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $12.32M 10-Q · filed 2020-05-04 | -$30.36M derived: sum of 2 quarters · filed 2020-08-06 | -$9.22M derived: sum of 3 quarters · filed 2020-08-06 | $12.95M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2018-12-31 | -$42.68M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-08-06 | -$21.54M derived: sum of 2 quarters · filed 2020-08-06 | $627.00K derived: sum of 3 quarters · filed 2020-08-06 | $23.64M 10-Q · filed 2020-08-06 | $85.16M 10-K · filed 2019-03-04 |
| 2018-09-30 | $21.14M 10-Q · filed 2019-11-12 | $43.30M derived: sum of 2 quarters · filed 2019-11-12 | $66.32M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $22.16M 10-Q · filed 2019-08-01 | $45.18M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $23.02M 10-Q · filed 2019-05-06 | ||||
| 2017-12-31 | $30.85M 10-K · filed 2019-03-04 | ||||
| 2016-12-31 | $16.70M 10-K · filed 2019-03-04 |